Wang L - Search Results

1

CDK4/6 inhibition promotes immune infiltration in ovarian cancer and synergizes with PD-1 blockade in a B cell-dependent manner.

Zhang QF, Li J, Jiang K, Wang R, Ge JL, Yang H, Liu SJ, Jia LT, Wang L, Chen BL. Zhang QF, et al. Among authors: wang l, wang r. Theranostics. 2020 Aug 25;10(23):10619-10633. doi: 10.7150/thno.44871. eCollection 2020. Theranostics. 2020. PMID: 32929370 Free PMC article.

2

Long non-coding RNAs AC026904.1 and UCA1: a "one-two punch" for TGF-β-induced SNAI2 activation and epithelial-mesenchymal transition in breast cancer.

Li GY, Wang W, Sun JY, Xin B, Zhang X, Wang T, Zhang QF, Yao LB, Han H, Fan DM, Yang AG, Jia LT, Wang L. Li GY, et al. Among authors: wang w, wang l, wang t. Theranostics. 2018 Apr 15;8(10):2846-2861. doi: 10.7150/thno.23463. eCollection 2018. Theranostics. 2018. PMID: 29774079 Free PMC article.

3

SDF-1/CXCR4 axis facilitates myeloid-derived suppressor cells accumulation in osteosarcoma microenvironment and blunts the response to anti-PD-1 therapy.

Jiang K, Li J, Zhang J, Wang L, Zhang Q, Ge J, Guo Y, Wang B, Huang Y, Yang T, Hao D, Shan L. Jiang K, et al. Among authors: wang l, wang b. Int Immunopharmacol. 2019 Oct;75:105818. doi: 10.1016/j.intimp.2019.105818. Epub 2019 Aug 19. Int Immunopharmacol. 2019. PMID: 31437795 Free article.

4

Epigenetic silencing of miR-375 induces trastuzumab resistance in HER2-positive breast cancer by targeting IGF1R.

Ye XM, Zhu HY, Bai WD, Wang T, Wang L, Chen Y, Yang AG, Jia LT. Ye XM, et al. Among authors: wang l, wang t. BMC Cancer. 2014 Feb 26;14:134. doi: 10.1186/1471-2407-14-134. BMC Cancer. 2014. PMID: 24571711 Free PMC article.

5

MiR-221 promotes trastuzumab-resistance and metastasis in HER2-positive breast cancers by targeting PTEN.

Ye X, Bai W, Zhu H, Zhang X, Chen Y, Wang L, Yang A, Zhao J, Jia L. Ye X, et al. Among authors: wang l. BMB Rep. 2014 May;47(5):268-73. doi: 10.5483/bmbrep.2014.47.5.165. BMB Rep. 2014. PMID: 24286315 Free PMC article.

6

Missing Links in Epithelial-Mesenchymal Transition: Long Non-Coding RNAs Enter the Arena.

Wang L, Yang F, Jia LT, Yang AG. Wang L, et al. Cell Physiol Biochem. 2017;44(4):1665-1680. doi: 10.1159/000485766. Epub 2017 Dec 6. Cell Physiol Biochem. 2017. PMID: 29216625 Free article. Review.

7

MicroRNA-26a promotes anoikis in human hepatocellular carcinoma cells by targeting alpha5 integrin.

Zhang X, Cheng SL, Bian K, Wang L, Zhang X, Yan B, Jia LT, Zhao J, Gammoh N, Yang AG, Zhang R. Zhang X, et al. Among authors: wang l. Oncotarget. 2015 Feb 10;6(4):2277-89. doi: 10.18632/oncotarget.2956. Oncotarget. 2015. PMID: 25537511 Free PMC article.

8

Targeted delivery of CXCR4-siRNA by scFv for HER2(+) breast cancer therapy.

Jiang K, Li J, Yin J, Ma Q, Yan B, Zhang X, Wang L, Wang L, Liu T, Zhang Y, Fan Q, Yang A, Qiu X, Ma B. Jiang K, et al. Among authors: wang l. Biomaterials. 2015 Aug;59:77-87. doi: 10.1016/j.biomaterials.2015.04.030. Epub 2015 May 15. Biomaterials. 2015. PMID: 25956853

9

[Transmembrane prostate androgen-induced protein 1 (PMEPA1) promotes the migration and maintains mesenchymal-like phenotype of breast cancer cells].

Zou Y, Zhang Y, Wang T, Wang S, Yang A, Jia L, Wang L. Zou Y, et al. Among authors: wang l, wang t, wang s. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2016 Feb;32(2):158-62. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2016. PMID: 26927372 Chinese.

10

SIRT3 is correlated with the malignancy of non-small cell lung cancer.

Xiong Y, Wang M, Zhao J, Wang L, Li X, Zhang Z, Jia L, Han Y. Xiong Y, et al. Among authors: wang l, wang m. Int J Oncol. 2017 Mar;50(3):903-910. doi: 10.3892/ijo.2017.3868. Epub 2017 Feb 2. Int J Oncol. 2017. PMID: 28197634

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

147,211 results

Search Page

Filters